Top-selling products for drugmaker Merck & Co. The Associated Press ... $577 million $566 million Temodar Brain Cancer $292 million $242 million Nasonex Allergies $286 million $280 million Fosamax Osteoporosis $285 million ...
Merck Fails to Knock Out Third Fosamax Test Case Am Law Litigation Daily Maley's case is one of approximately 900 filed against Fosamax maker Merck, which has been accused of ignoring studies linking the osteoporosis drug to a ...
Compelling Companies With Competitive Advantages Motley Fool Rival drugs such as GlaxoSmithKline's (NYSE: GSK) Boniva aren't the only competitive danger to Merck's (NYSE: MRK) osteoporosis treatment, Fosamax. ...
Is big pharma just milking our fears? AsiaOne Thus the market for a drug like Fosomax (alendronate), made by Merck, which can slow down bone loss, is very small. Until the 1990s, osteoporosis was ...
2.Fosomax and jaw bone - Dental Health - MedHelp
This is a discussion on MedHelp about Fosomax and jaw bone. Community members of MedHelp provide help, support, guidance and discussion around the topic of ...